1. Home
  2. SILO vs ATXG Comparison

SILO vs ATXG Comparison

Compare SILO & ATXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • ATXG
  • Stock Information
  • Founded
  • SILO 2010
  • ATXG 2014
  • Country
  • SILO United States
  • ATXG China
  • Employees
  • SILO N/A
  • ATXG N/A
  • Industry
  • SILO Apparel
  • ATXG Professional Services
  • Sector
  • SILO Consumer Discretionary
  • ATXG Consumer Discretionary
  • Exchange
  • SILO Nasdaq
  • ATXG Nasdaq
  • Market Cap
  • SILO 4.7M
  • ATXG 3.9M
  • IPO Year
  • SILO N/A
  • ATXG N/A
  • Fundamental
  • Price
  • SILO $0.84
  • ATXG $0.63
  • Analyst Decision
  • SILO
  • ATXG
  • Analyst Count
  • SILO 0
  • ATXG 0
  • Target Price
  • SILO N/A
  • ATXG N/A
  • AVG Volume (30 Days)
  • SILO 596.1K
  • ATXG 13.0K
  • Earning Date
  • SILO 11-12-2024
  • ATXG 02-12-2025
  • Dividend Yield
  • SILO N/A
  • ATXG N/A
  • EPS Growth
  • SILO N/A
  • ATXG N/A
  • EPS
  • SILO N/A
  • ATXG N/A
  • Revenue
  • SILO $72,102.00
  • ATXG $4,958,444.00
  • Revenue This Year
  • SILO $1.86
  • ATXG N/A
  • Revenue Next Year
  • SILO N/A
  • ATXG N/A
  • P/E Ratio
  • SILO N/A
  • ATXG N/A
  • Revenue Growth
  • SILO N/A
  • ATXG N/A
  • 52 Week Low
  • SILO $0.77
  • ATXG $0.49
  • 52 Week High
  • SILO $4.50
  • ATXG $1.77
  • Technical
  • Relative Strength Index (RSI)
  • SILO 40.96
  • ATXG 48.03
  • Support Level
  • SILO $0.77
  • ATXG $0.59
  • Resistance Level
  • SILO $0.99
  • ATXG $0.66
  • Average True Range (ATR)
  • SILO 0.10
  • ATXG 0.05
  • MACD
  • SILO 0.00
  • ATXG 0.00
  • Stochastic Oscillator
  • SILO 23.30
  • ATXG 50.38

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About ATXG Addentax Group Corp.

Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.

Share on Social Networks: